BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1532615)

  • 1. Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis.
    Guay DR; Craft JC
    J Intern Med; 1992 Mar; 231(3):295-301. PubMed ID: 1532615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitis.
    Bachand RT
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():91-100. PubMed ID: 1827107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis.
    Aldons PM
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():101-8. PubMed ID: 1827095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin in the treatment of bacterial relapses of chronic bronchitis.
    Dericoloso A; Sanduzzi A; Cuccurullo S; Sarno M; Bianco A; Moro RA
    Riv Eur Sci Med Farmacol; 1991; 13(5-6):275-83. PubMed ID: 1840282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Hosie J; Quinn P; Smits P; Sides G
    J Antimicrob Chemother; 1995 Jul; 36(1):173-83. PubMed ID: 8537264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
    Anzueto A; Niederman MS; Tillotson GS
    Clin Ther; 1998; 20(5):885-900. PubMed ID: 9829441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
    Bradbury F
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():153-62. PubMed ID: 8396087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis.
    Fraschini F
    J Int Med Res; 1990; 18(2):171-6. PubMed ID: 2140331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P; Dobryniewska M; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
    Poirier R
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():109-16. PubMed ID: 1827096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis.
    Gaillat J
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis.
    Wettengel R; Vetter N; Waardenburg FA
    J Antimicrob Chemother; 1993 Jun; 31(6):963-72. PubMed ID: 8360133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis.
    Wilson R; Kubin R; Ballin I; Deppermann KM; Bassaris HP; Leophonte P; Schreurs AJ; Torres A; Sommerauer B
    J Antimicrob Chemother; 1999 Oct; 44(4):501-13. PubMed ID: 10588312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE; Zuck P; Vogel F; McIvor A; Peirzchala W; Smakal M; Staley H; Marr C
    J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Busman TA; Norris S; Notario GF
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia.
    Straneo G; Scarpazza G
    J Int Med Res; 1990; 18(2):164-70. PubMed ID: 2140330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis.
    Ziering W; McElvaine P
    Infection; 1998; 26(1):68-75. PubMed ID: 9505188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
    Müller O
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():137-46. PubMed ID: 8396085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
    Sides GD
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.